AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 94 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $5,000 | -28.6% | 788 | -54.7% | 0.00% | – |
Q3 2019 | $7,000 | -30.0% | 1,739 | -14.9% | 0.00% | – |
Q2 2019 | $10,000 | 0.0% | 2,043 | +64.0% | 0.00% | – |
Q1 2019 | $10,000 | +42.9% | 1,246 | -4.7% | 0.00% | – |
Q4 2018 | $7,000 | +600.0% | 1,307 | +2115.3% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | – | 59 | 0.0% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 59 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | -50.0% | 59 | -53.2% | 0.00% | – |
Q4 2015 | $2,000 | – | 126 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,642,000 | 3.05% |
Orchard Capital Management, LLC | 251,826 | $89,000 | 0.03% |
Bayesian Capital Management, LP | 304,100 | $107,000 | 0.02% |
Icon Wealth Partners, LLC | 400,132 | $141,000 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,339,043 | $2,592,000 | 0.01% |
Ergoteles LLC | 849,000 | $300,000 | 0.01% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
HRT FINANCIAL LP | 1,103,737 | $389,000 | 0.00% |
Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 777,617 | $275,000 | 0.00% |